SFG
ASND icon

Steward Financial Group’s Ascendis Pharma A/S ASND Stock Holding History

Steward Financial Group’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1
Closed – – 464
2023
Q1 		$0 Hold
1
– – ﹤0.01% 719
2022
Q4 		$0 Buy
+1
New +$116 ﹤0.01% 543
2022
Q3 		– Sell
-1
Closed – – 146
2022
Q2 		$0 Buy
+1
New +$94 ﹤0.01% 966

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Steward Financial Group's ASND Position: Q2 2023 in Review

Steward Financial Group sold out of Ascendis Pharma A/S (ASND) in Q2 2023, closing a stake of 1 share.

Steward Financial Group first reported a position in ASND in Q2 2022 and held it in 3 quarters. The position peaked at $0 in Q1 2023. 158 funds tracked by Wall St. Rank hold ASND as of Q2 2023.

  • Steward Financial Group reported no remaining Ascendis Pharma A/S position as of Q2 2023 after selling out during the quarter.
  • Steward Financial Group sold 1 Ascendis Pharma A/S share in Q2 2023.
  • Steward Financial Group first reported a position in Ascendis Pharma A/S in Q2 2022 and held it in 3 quarters.
  • Steward Financial Group's Ascendis Pharma A/S position peaked at $0 in Q1 2023.
  • 158 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2023.

Based on Steward Financial Group's 13F filing for Q2 2023, filed 7 Aug 2023.